NCCN Guidelines recommend regular office visits, lab testing, and imaging studies, but there is a wide range of recommendations for the frequency, i.e. 6 weeks to 6 months and these are not based on prospective data. NCCN and ASCO guidelines recommend that metastatic disease be monitored in selected...